Literature DB >> 10886141

Cytokine profiles in spontaneously regressing basal cell carcinomas.

D A Wong1, G A Bishop, M A Lowes, B Cooke, R S Barnetson, G M Halliday.   

Abstract

BACKGROUND: Basal cell carcinomas (BCCs) can cause considerable morbidity due to their ability to enlarge progressively and to destroy underlying tissues. However, some BCCs may undergo spontaneous regression in the absence of therapy capable of inducing antineoplastic effects. Histological criteria for this process have been described, and previous studies have suggested that it may be mediated by infiltrating activated CD4-positive T cells.
OBJECTIVES: The purpose of this study was to compare the expression of cytokines in actively regressing and non-regressing BCCs, to ascertain if active regression is associated with a particular cytokine profile.
METHODS: Reverse transcriptase-polymerase chain reaction, a sensitive, quantitative technique allowing analysis of multiple cytokines from small tumour samples, was used.
RESULTS: Interferon (IFN)-gamma was significantly elevated in actively regressing BCCs compared with non-regressing BCCs. Furthermore, interleukin (IL)-2, tumour necrosis factor (TNF)-beta and CD3 delta tended to be elevated in actively regressing tumours, although not to statistically significant levels. IFN-gamma, IL-2, IL-10, TNF-beta, granulocyte-macrophage colony-stimulating factor and Fas ligand showed strong positive correlations with CD3 delta, indicating an association between infiltrating T cells and these cytokines.
CONCLUSIONS: These findings support a role for T-helper 1 type cytokines in mediating spontaneous regression of BCCs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886141     DOI: 10.1046/j.1365-2133.2000.03596.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  16 in total

1.  'The nodule that disappeared' spontaneous regression of an eyelid noduloulcerative lesion mimicking the features of a basal cell carcinoma.

Authors:  Tafadzwa Young-Zvandasara; Magdalena Popiela; Garry Shuttleworth
Journal:  BMJ Case Rep       Date:  2015-01-29

2.  Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.

Authors:  Karin A Vineretsky; Margaret R Karagas; Brock C Christensen; Jacquelyn K Kuriger-Laber; Ann E Perry; Craig A Storm; Heather H Nelson
Journal:  Cancer Res       Date:  2016-01-07       Impact factor: 12.701

3.  Regression of Periocular Basal Cell Carcinoma: A Report of Four Cases with Clinicopathologic Correlation.

Authors:  Martina C Herwig-Carl; Karin U Loeffler
Journal:  Ocul Oncol Pathol       Date:  2019-08-28

4.  Basal cell carcinoma with spontaneous regression: a case report and immunohistochemical study.

Authors:  Taku Fujimura; Aya Kakizaki; Yumi Kambayashi; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2012-06-05

5.  Tumor site immune markers associated with risk for subsequent basal cell carcinomas.

Authors:  Ronald Glaser; Rebecca Andridge; Eric V Yang; Arwa Y Shana'ah; Michael Di Gregorio; Min Chen; Sheri L Johnson; Lawrence A De Renne; David R Lambert; Scott D Jewell; Mark A Bechtel; Dean W Hearne; Joel Bain Herron; Janice K Kiecolt-Glaser
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

6.  -2518 A/G MCP-1 but not -403 G/A RANTES gene polymorphism is associated with enhanced risk of basal cell carcinoma.

Authors:  Michał Sobjanek; Monika Zabłotna; Aneta Szczerkowska-Dobosz; Katarzyna Ruckemann-Dziurdzińska; Malgorzata Sokolowska-Wojdylo; Roman Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

7.  Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments.

Authors:  Cristina Pellegrini; Augusto Orlandi; Gaetana Costanza; Alessandro Di Stefani; Antonella Piccioni; Antonella Di Cesare; Andrea Chiricozzi; Amedeo Ferlosio; Ketty Peris; Maria Concetta Fargnoli
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

8.  Immunoprevention of basal cell carcinomas with recombinant hedgehog-interacting protein.

Authors:  Annika Vogt; Pao-Tien Chuang; Jennifer Hebert; Jimmy Hwang; Ying Lu; Levy Kopelovich; Mohammad Athar; David R Bickers; Ervin H Epstein
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307

9.  Depletion of cutaneous macrophages and dendritic cells promotes growth of basal cell carcinoma in mice.

Authors:  Simone König; Frauke Nitzki; Anja Uhmann; Kai Dittmann; Jennifer Theiss-Suennemann; Markus Herrmann; Holger M Reichardt; Reto Schwendener; Tobias Pukrop; Walter Schulz-Schaeffer; Heidi Hahn
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

Review 10.  Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma.

Authors:  Mihai Lupu; Constantin Caruntu; Mihaela Adriana Ghita; Vlad Voiculescu; Suzana Voiculescu; Adrian E Rosca; Ana Caruntu; Liliana Moraru; Iris Maria Popa; Bogdan Calenic; Maria Greabu; Daniela Elena Costea
Journal:  Dis Markers       Date:  2016-08-08       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.